3 results match your criteria: "Faculty of Health and Medicine University of Sydney[Affiliation]"
Methadone-Buprenorphine Transfers Using Low Dosing of Buprenorphine: An Open-Label, Nonrandomized Clinical Trial.
J Addict Med
December 2024
From the Alcohol and Drug Services St Vincent's Hospital, Sydney, Australia (CT); Sydney Local Health District Drug Health Services, Sydney, Australia (CT, JB, NJ, PH); University of Sydney, Sydney, Australia (CT); Drug Health Services, South Western Sydney Local Health District, Sydney, Australia (RH); Northern Sydney Local Health District, Drug & Alcohol Service, Sydney, Australia (NM); Drug and Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, Australia (CI); South Eastern Sydney Local Health District, Drug and Alcohol Services, Sydney, Australia (RP, NL); UNSW Sydney (RP); Division Addiction Medicine, Central Clinical School; South Eastern Sydney Local Health District, Drug and Alcohol Services, NSW Drug and Alcohol Clinical Research and Improvement Network (DACRIN), Sydney, Australia (LM, NL, PH); NSW Poisons Centre, Sydney, Australia (NB); Edith Collins Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia (NB, VP, PH); Clinical Pharmacology and Toxicology Research Group, Biomedical Informatics & Digital Health, Sydney Medical School, University of Sydney, Sydney, Australia (NB, VP); NSW Health Speciality of Addiction Medicine, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia (NL); and Faculty of Health and Medicine University of Sydney, Sydney, Australia (NJ, PH).
Aims: To compare a low-dosing protocol to standard practice for methadone-buprenorphine transfers.
Methods: We undertook a nonrandomized open-label clinical trial across 8 sites from NSW, Australia. Participants prescribed methadone wishing to transfer to buprenorphine could either choose or be randomized to a low-dose transfer or standard care transfer as per NSW health guidelines.
Low Risk of Cardiac Complications During Long-Term Follow-Up of Opioid Dependence.
J Addict Med
October 2024
From the Alcohol and Drug Services, St Vincent's Hospital, Sydney, Australia (CT); Drug and Alcohol Department RPA Hospital, Sydney, Australia (CT); Faculty of Medicine and Health, University of Sydney (CT, DSC); Department of Cardiology, RPA Hospital (DS); Heart Research Institute (DSC); University of Sydney Matilda Centre for Research in Mental Health and Substance Use, Sydney, NSW, Australia (CM, KM, JW, TS, MT); Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia (SF); Department of Cardiology, North Shore Hospital, Auckland, New Zealand (SF); Macquarie University (TS); Black Dog Institute (TS); and Drug Health Services RPA Hospital, Faculty of Health and Medicine University of Sydney, Sydney, Australia (PH).
Objectives: To prospectively assess rates of QT prolongation, arrhythmia, syncope, and sudden cardiac death (SCD) in a cohort of people with heroin dependence.
Methods: To estimate rates of QT prolongation, arrhythmia, and syncope, a subcohort (n = 130) from the Australian Treatment Outcomes Study, a prospective longitudinal cohort study of 615 people with heroin dependence, underwent medical history, venepuncture, and ECG at the 18- to 20-year follow-up.To estimate rates of SCD, probabilistic matching for the entire cohort was undertaken with the Australian Institute of Health and Welfare National Death Index.
Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective.
Am J Respir Crit Care Med
March 2021
Department of Respiratory Medicine Royal Prince Alfred Hospital Camperdown, New South Wales, Australia and.